ArticleBMC infectious diseases2013

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

Tjalke A Westra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.